Pharma Marketing Network

By Stephen Towers, PhD The program for this year’s Biotech Showcase Digital – the leading investor and networking conference for mostly small- and mid-cap biotechnology companies – highlighted several important advances in...

Scientia Meetings cordially invites all the participants from all over the world to attend “International Conference on Pharmaceutical Research and Drug Development" which will be held during September 20-22, 2021 in...

Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Pharma marketers have quickly learned how to adapt to...

2020 was a year defined by unexpected challenges – and related opportunity - for pharmaceutical marketers. The COVID-19 pandemic pushed the industry to experiment with new media, emerging technologies and innovative...

What will stay the same in 2021? “COVID accelerated our 5-year digital transformation plan into a 5-month plan”. That client comment was amazingly accurate. While initially we saw a great deal of...

Almost two decades after the human genome was sequenced, a trickle of new genetic medicines (i.e., those that modify the expression of an individual’s genes or repair abnormal genes) has entered...

The 2021 NextGen Pharma Content, taking place on March 23-24, will bring together content creators, marketers, and communications/PR practitioners to learn how to build trust and earn loyalty with customers to achieve a...

Highlights from Reuters Events, Pharma Awards USA 2020 - Day 1 With access to over 60 of the industry’s shining case studies, the 2020 USA Pharma Awards held its virtual ceremony on...

An extensive report by eMarketer, AI In Drug Discovery and Development, discusses how AI can speed up the drug discovery and development process while eliminating costs, how startups are taking first...

Biotech Showcase™ Digital is an investor and networking conference devoted to providing private and micro-mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives. We are committed...